Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas
Kinga Németh(Semmelweis University), Henriett Butz(St. Michael's Hospital)
Cited by 8
Related Papers
Non-coding RNAs in disease: from mechanisms to therapeutics
|Nature Reviews Genetics|2023|779
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1
|Oncotarget|2015|82
Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis
|Oncotarget|2017|30
Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma
|The Journal of Clinical Endocrinology & Metabolism|2022|10